FI900470A0 - Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning. - Google Patents

Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.

Info

Publication number
FI900470A0
FI900470A0 FI900470A FI900470A FI900470A0 FI 900470 A0 FI900470 A0 FI 900470A0 FI 900470 A FI900470 A FI 900470A FI 900470 A FI900470 A FI 900470A FI 900470 A0 FI900470 A0 FI 900470A0
Authority
FI
Finland
Prior art keywords
release
pharmaceutical
preparation
controlled
kontrollerat
Prior art date
Application number
FI900470A
Other languages
English (en)
Finnish (fi)
Inventor
Udo Wenzel
Jurgen Metzner
Thomas Rosin
Halvor Jaeger
Zoser B Salama
Original Assignee
Int Pharma Agentur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25748261&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI900470(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DD89325354A external-priority patent/DD295760A5/de
Priority claimed from DE19893932987 external-priority patent/DE3932987A1/de
Application filed by Int Pharma Agentur filed Critical Int Pharma Agentur
Publication of FI900470A0 publication Critical patent/FI900470A0/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Filling Or Discharging Of Gas Storage Vessels (AREA)
  • Operation Control Of Excavators (AREA)
  • External Artificial Organs (AREA)
FI900470A 1989-01-31 1990-01-30 Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning. FI900470A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DD89325354A DD295760A5 (de) 1989-01-31 1989-01-31 Arzneistoffreigabesystem mit kotrollierter wirkstoffreisetzung
DE19893932987 DE3932987A1 (de) 1989-10-03 1989-10-03 System fuer die kontrollierte freisetzung von wirkstoffen und verfahren zu seiner herstellung

Publications (1)

Publication Number Publication Date
FI900470A0 true FI900470A0 (fi) 1990-01-30

Family

ID=25748261

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900470A FI900470A0 (fi) 1989-01-31 1990-01-30 Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.

Country Status (13)

Country Link
EP (1) EP0381181B1 (es)
JP (1) JP2885858B2 (es)
AT (1) ATE126052T1 (es)
AU (1) AU641136B2 (es)
CA (1) CA2009045A1 (es)
DE (1) DE69021405T2 (es)
DK (1) DK0381181T3 (es)
ES (1) ES2078251T3 (es)
FI (1) FI900470A0 (es)
GR (1) GR3017861T3 (es)
HU (1) HU205851B (es)
IE (1) IE69174B1 (es)
NO (1) NO301520B1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
WO1996019974A1 (fr) * 1994-12-27 1996-07-04 Kanebo, Ltd. Preparation a liberation prolongee
US5558879A (en) * 1995-04-28 1996-09-24 Andrx Pharmaceuticals, Inc. Controlled release formulation for water soluble drugs in which a passageway is formed in situ
US6074669A (en) * 1997-01-20 2000-06-13 Ranbaxy Laboratories Limited Controlled drug delivery system for diltiazem
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
RU2322233C2 (ru) * 2002-03-11 2008-04-20 Алькон, Инк. Имплантируемая система для доставки лекарственных средств
US7785627B2 (en) 2002-09-20 2010-08-31 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US8084058B2 (en) 2002-09-20 2011-12-27 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US7959946B2 (en) 2002-09-20 2011-06-14 Watson Pharmaceuticals, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
US9060941B2 (en) 2002-09-20 2015-06-23 Actavis, Inc. Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
GB2150434B (en) * 1983-12-01 1987-11-04 Alza Corp Constant rate release systems
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form
EP0250374B1 (en) * 1986-06-17 1991-05-02 RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA S.p.a. Therapeutic system for controlled release of drugs
US4801461A (en) * 1987-01-28 1989-01-31 Alza Corporation Pseudoephedrine dosage form

Also Published As

Publication number Publication date
DE69021405D1 (de) 1995-09-14
DK0381181T3 (da) 1995-10-30
NO301520B1 (no) 1997-11-10
CA2009045A1 (en) 1990-07-31
EP0381181B1 (en) 1995-08-09
IE900336L (en) 1990-07-31
JP2885858B2 (ja) 1999-04-26
AU4898890A (en) 1990-08-09
EP0381181A3 (en) 1991-09-18
EP0381181A2 (en) 1990-08-08
HU900591D0 (en) 1990-04-28
JPH02282324A (ja) 1990-11-19
ES2078251T3 (es) 1995-12-16
IE69174B1 (en) 1996-08-07
AU641136B2 (en) 1993-09-16
NO900428L (no) 1990-08-01
DE69021405T2 (de) 1996-04-11
GR3017861T3 (en) 1996-01-31
NO900428D0 (no) 1990-01-30
HUT53284A (en) 1990-10-28
ATE126052T1 (de) 1995-08-15
HU205851B (en) 1992-07-28

Similar Documents

Publication Publication Date Title
NO166448C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner.
RU98111594A (ru) Фармацевтические композиции, включающие флурбипрофен
DE3773468D1 (de) Hydromorphon-zusammensetzung mit gesteuerter wirkstofffreisetzung.
IE790756L (en) Cerebral therapeutic agent
DK0610595T3 (da) Sammensætning af L-DOPA-estere
JPH09501652A (ja) グリセロールエステルと組み合わせたヘパリン、ヘパリン断片またはそれらの派生物を含有する薬剤組生物
ATE154239T1 (de) Sphäroidische arzneimittelformulierung
FI900470A0 (fi) Aktivaemnen kontrollerat avgivande system och foerfarande foer dess framstaellning.
WO2002064148A3 (en) Oral formulations containing mucopolysaccharide for small intestine delivery and their use in the treatment circulatory disorders
CA2314571A1 (en) Methods and compositions for treating diseases and conditions of the eye
EG19302A (en) Compound with gastric acid inhibitory effect and process for its preparation
DK1009380T3 (da) Fremgangsmåde til fremstilling af farmaceutiske formuleringer
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
ATE55248T1 (de) Arzneimittelkombination.
IE44030L (en) Ó-amino-ketones.
KR900701278A (ko) 바이러스 감염 치료용 담즙산
US4298611A (en) Process for reducing blood pressure in animals
ATE110266T1 (de) Verfahren zum regeln der absorptionsrate von arzneimitteln sowie arzneimittelformulierung.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
IE873463L (en) Compositions
KR890001555A (ko) 요산 배설용 조성물
JPS643123A (en) Remedy for skin inflammation
BG103351A (en) Medicamentous form with extended release
KR890002058A (ko) 간질 및 불안 상태의 예방 및 치료용 2,4,6-트리스-3-급-부틸아미노-1,-3,-5-트리아진

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: IPA INTERNATIONALE PHARMA AGENTUR GMBH